Catalyst
Slingshot members are tracking this event:
FDA Grants Fast Track Designation for Astellas (ALPMY) and Immunomic Therapeutics' ASP0892 for the Mitigation of Severe Hypersensitivity Reactions due to Peanut Allergy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALPMY |
|
|
Immunomic Therapeutics |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 20, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Fast Track Review, Asp0892, Severe Hypersensitivity, Peanut Allergies
